PDS: Neutralization of Multiple Influenza Strains in Preclinical Studies

 

• PDS0202 (Infectimune^® + COBRA influenza antigens) vaccination also prevented illness/weight loss
• Vaccine protected against replication of the virus in the lungs of ferrets after challenge with the H1N1 virus
• Data from Cleveland Clinic’s Ted Ross Lab presented at the 9^th ESWI Influenza Conference

https://www.biospace.com/article/releases/pds-biotech-announces-pds0202-elicits-active-neutralization-of-multiple-influenza-strains-in-preclinical-studies/